P. D. O. Davies (Liverpool, United Kingdom), L. Codecasa (Milano, Italy)
Treatment of latent tuberculosis infection: completion rates and adverse effects
R. L. Cowie, H. Bent (Calgary, Canada)
|  |
Impact of socioeconomic factors upon in-hospital tuberculosis management
Y. Rosati, G. P. Mattioli, G. Carosella, M. Bocchino, P. Piselli, E. Girardi, C. Saltini (Rome, Italy)
| |
Iasi, the first Romanian DOTS pilot project; the five years experience of practice
A. Sorete-Arbore, T. Mihaescu (Iasi, Romania)
| |
Why did the tuberculous patients abandon their treatment? A patient questionnaire
M. C. Ciontu, C. I. Oprea, A. V. Halpern, L. Spalatelu (Bucharest, Romania)
|  |
The results of the antituberculosis treatment to the patients with pulmonary tuberculosis in Bucharest (Romania) in 2001
C. D. Marica, C. I. Didilescu, V. D. Spinu, N. D. Galie (Bucharest, Romania)
| |
New method of treatment of MDR destructive pulmonary tuberculosis
V. G. Dobkin, D. R. Fayzulin, G. P. Kuzmin, M. A. Bagirov (Moscow, Russia)
| |
Phase I-II clinical trials of gamma-Glu-Trp in patients with lung tuberculosis
A. S. Simbirtsev, A. A. Kolobov, V. E. Bokovanov, G. Y. Vasilieva, C. Tuthill, A. Rudolph (St Petersburg, Russia; San Mateo, United States Of America)
| |
First data about the efficacy of moxifloxacin in the treatment of pulmonary tuberculosis – a prospective, randomised study versus INH
M. W. Pletz, A. Deroux, A. Roth, H. Mauch, H. Lode (Berlin, Germany)
| |